1. Decline in tuberculosis with 19 years of universal directly observed therapy in a comprehensive statewide program.
- Author
-
Webb RM, Penman A, Holcombe M, Dobbs T, and Mathew TA
- Subjects
- Adolescent, Adult, Aged, Antibiotics, Antitubercular therapeutic use, Centers for Disease Control and Prevention, U.S., Child, Child, Preschool, Databases, Factual, Female, Health Policy, Humans, Infant, Infant, Newborn, Logistic Models, Male, Middle Aged, Mississippi epidemiology, Pyrazinamide therapeutic use, Rifampin therapeutic use, Rural Population, United States, Young Adult, Antitubercular Agents therapeutic use, Directly Observed Therapy statistics & numerical data, Tuberculosis drug therapy, Tuberculosis epidemiology
- Abstract
The Mississippi State Department of Health tuberculosis program serves a rural southeastern US state of 2.9 million people in an area of 121,489 km(2) (46,907 square miles). Statewide, directly observed therapy (DOT) began in 1986. To evaluate the program's effectiveness, trends in Centers for Disease Prevention and Control program indicators for 1981-2005 were compared and found to be significant (P < 0.0001). Inclusion of rifampin and pyrazinamide in the regimens was reviewed. An annual decline in cases and case rates began in 1990, falling by 65% by 2005. Successful DOT is feasible over a large geographic area.
- Published
- 2011
- Full Text
- View/download PDF